日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/07/18 | 4,410 | 4,480 | 4,410 | 4,410 | -45 | -1% | 1,600 |
| 2018/07/17 | 4,425 | 4,505 | 4,425 | 4,455 | +15 | +0.3% | 1,600 |
| 2018/07/13 | 4,425 | 4,440 | 4,425 | 4,440 | +15 | +0.3% | 900 |
| 2018/07/12 | 4,385 | 4,425 | 4,370 | 4,425 | +15 | +0.3% | 500 |
| 2018/07/11 | 4,440 | 4,510 | 4,410 | 4,410 | -70 | -1.6% | 1,200 |
| 2018/07/10 | 4,540 | 4,615 | 4,480 | 4,480 | -85 | -1.9% | 2,500 |
| 2018/07/09 | 4,560 | 4,630 | 4,550 | 4,565 | -65 | -1.4% | 3,100 |
| 2018/07/06 | 4,630 | 4,630 | 4,520 | 4,630 | +280 | +6.4% | 4,500 |
| 2018/07/05 | 4,415 | 4,430 | 4,350 | 4,350 | -110 | -2.5% | 1,800 |
| 2018/07/04 | 4,430 | 4,490 | 4,430 | 4,460 | +35 | +0.8% | 1,400 |
| 2018/07/03 | 4,630 | 4,655 | 4,425 | 4,425 | -225 | -4.8% | 3,200 |
| 2018/07/02 | 4,655 | 4,655 | 4,635 | 4,650 | -25 | -0.5% | 400 |
| 2018/06/29 | 4,670 | 4,760 | 4,625 | 4,675 | +10 | +0.2% | 3,100 |
| 2018/06/28 | 4,675 | 4,705 | 4,620 | 4,665 | -10 | -0.2% | 1,700 |
| 2018/06/27 | 4,750 | 4,820 | 4,675 | 4,675 | -75 | -1.6% | 1,100 |
| 2018/06/26 | 4,710 | 4,760 | 4,710 | 4,750 | -15 | -0.3% | 1,900 |
| 2018/06/25 | 4,790 | 4,820 | 4,730 | 4,765 | -25 | -0.5% | 3,100 |
| 2018/06/22 | 4,675 | 4,790 | 4,645 | 4,790 | +150 | +3.2% | 3,600 |
| 2018/06/21 | 4,640 | 4,640 | 4,615 | 4,640 | +10 | +0.2% | 2,400 |
| 2018/06/20 | 4,535 | 4,630 | 4,535 | 4,630 | +95 | +2.1% | 1,400 |
| 2018/06/19 | 4,600 | 4,600 | 4,535 | 4,535 | -55 | -1.2% | 1,300 |
| 2018/06/18 | 4,680 | 4,680 | 4,590 | 4,590 | -90 | -1.9% | 600 |
| 2018/06/15 | 4,585 | 4,695 | 4,585 | 4,680 | +70 | +1.5% | 3,000 |
| 2018/06/14 | 4,535 | 4,610 | 4,535 | 4,610 | +40 | +0.9% | 2,200 |
| 2018/06/13 | 4,560 | 4,585 | 4,550 | 4,570 | -20 | -0.4% | 800 |
| 2018/06/12 | 4,600 | 4,600 | 4,585 | 4,590 | -30 | -0.6% | 1,600 |
| 2018/06/11 | 4,575 | 4,640 | 4,575 | 4,620 | -5 | -0.1% | 1,200 |
| 2018/06/08 | 4,650 | 4,655 | 4,605 | 4,625 | +25 | +0.5% | 3,300 |
| 2018/06/07 | 4,600 | 4,670 | 4,530 | 4,600 | -10 | -0.2% | 1,500 |
| 2018/06/06 | 4,600 | 4,615 | 4,590 | 4,610 | -45 | -1% | 1,400 |
| 2018/06/05 | 4,665 | 4,680 | 4,630 | 4,655 | -80 | -1.7% | 1,400 |
| 2018/06/04 | 4,700 | 4,735 | 4,690 | 4,735 | +35 | +0.7% | 1,600 |
| 2018/06/01 | 4,575 | 4,700 | 4,525 | 4,700 | +125 | +2.7% | 3,000 |
| 2018/05/31 | 4,650 | 4,650 | 4,575 | 4,575 | -95 | -2% | 2,200 |
| 2018/05/30 | 4,670 | 4,670 | 4,670 | 4,670 | -50 | -1.1% | 500 |
| 2018/05/29 | 4,720 | 4,720 | 4,720 | 4,720 | +5 | +0.1% | 400 |
| 2018/05/28 | 4,720 | 4,720 | 4,715 | 4,715 | +30 | +0.6% | 1,800 |
| 2018/05/25 | 4,705 | 4,705 | 4,665 | 4,685 | -20 | -0.4% | 1,400 |
| 2018/05/24 | 4,685 | 4,705 | 4,665 | 4,705 | -25 | -0.5% | 2,800 |
| 2018/05/23 | 4,665 | 4,730 | 4,665 | 4,730 | +65 | +1.4% | 700 |
| 2018/05/22 | 4,645 | 4,735 | 4,645 | 4,665 | -35 | -0.7% | 4,200 |
| 2018/05/21 | 4,675 | 4,725 | 4,605 | 4,700 | -40 | -0.8% | 1,800 |
| 2018/05/18 | 4,750 | 4,755 | 4,685 | 4,740 | -15 | -0.3% | 500 |
| 2018/05/17 | 4,510 | 4,755 | 4,510 | 4,755 | +245 | +5.4% | 3,900 |
| 2018/05/16 | 4,455 | 4,520 | 4,455 | 4,510 | +105 | +2.4% | 1,500 |
| 2018/05/15 | 4,585 | 4,630 | 4,405 | 4,405 | -230 | -5% | 3,400 |
| 2018/05/14 | 4,490 | 4,695 | 4,490 | 4,635 | -145 | -3% | 3,900 |
| 2018/05/11 | 4,790 | 4,795 | 4,725 | 4,780 | -10 | -0.2% | 1,300 |
| 2018/05/10 | 4,795 | 4,795 | 4,765 | 4,790 | +25 | +0.5% | 1,200 |
| 2018/05/09 | 4,725 | 4,795 | 4,710 | 4,765 | +110 | +2.4% | 1,700 |
1551～
1600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
